4-[2-(1H-pyrazol-1-yl)ethyl]piperidine, 95.0%, 250mg

N-sec-Butylurea, 98%+, 500g

Embudo de separación según. a Squibb, 500 ml, 2 Pieza(s)

2-Chloro-5-methoxynicotinic acid, 95.0%, 1g

(2S,2'S,3S,3'S)-3,3'-Di-tert-butyl-2,2'-diisopropyl-2,2',3,3'-tetrahydro-4,4'-bibenzo[d][1,3]oxaphosphole, 97% 99%ee, 100mg

3-(tert-Butyl)-1,2,4-thiadiazol-5-amine, 95.0%, 250mg

N-(Prop-2-yn-1-yl)benzamide, 97%, 1g

[1,2,4]Triazolo[4,3-a]pyridine-3-thiol, 97.0%, 250mg

2-(4-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl)isothiazolidine 1,1-dioxide, 98%, 5g

1-(2-Fluorophenyl)-1H-pyrazole-4-carboxylic acid, 95.0%, 250mg

2-Bromo-1-(3-fluoro-4-methoxyphenyl)ethanone, 95+%, 250mg

Ethyl 4-oxotetrahydro-2H-pyran-2-carboxylate, 95.0%, 1g

Methanesulfonic acid, 1,1,1-trifluoro-, compd. with 1H-imidazole (1:1), 98%, 100g